- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04161443
Effect of Quadratus Lumborum Muscle Energy Technique in Sacroilliac Joint Dysfunction.
Effect of Quadratus Lumborum Muscle Energy Technique Along With Gluteus Medius Strengthening Verus Gluteus Medius Strengthening Alone in the Management of Sacroilliac Joint Dysfunction.; A Randomized Controlled Trial.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: saeed Akhtar
- Phone Number: +923312049179
- Email: saeed787@hotmail.com
Study Contact Backup
- Name: shehzad ali
- Phone Number: +923132340231
- Email: duhsmsphysio@gmail.com
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74200
- Institute of physical medicine and rehabilitation, Dow University of health sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Subjects with unilateral non-specific LBP
- The Subjects having at least 3 pain provocative tests of SIJ positive out of 5.
- Age 30-50 years. Both male and female.
- Pain history greater than six weeks.
- SIJ diagnostic scoring cut off point 4.
- VAS cut off point mild to moderate.
Exclusion Criteria:
- Radiating pain with sensory or motor deficits.
- History of fracture or any spinal surgery
- Trauma
- Any dysfunction of hip or knee
- Any systemic disease.
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Following physiotherapy treatment will be given to the participants in this group for 4 weeks and each session last for 30 minutes. i. MET Quadratus lumborum ii. Ultrasound iii. Gluteus medius exercises iv. Hamstring stretch Posture advice and home exercise program |
|
Active Comparator: Comparator
Following physiotherapy treatment will be given to the participants in this group for 4 weeks and each session last for 30 minutes. i. Ultrasound ii.Gluteus medius exercises iii.Hamstring stretch |
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual analog scale to measure the change in level of Pain intensity
Time Frame: Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
A Visual Analogue ScalE is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end ranging from no pain to severe pain.
|
Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
Oswestry Disability Index to measure change in level of disability
Time Frame: Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
Change in level of disability as evaluated by means of Oswestry Disability Index 2.0 (ODI)
|
Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
SF-36 QUALITY OF LIFE to measure change in general health
Time Frame: Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline and 12th session at the end of 4th week.
|
SF-36 measure 8 different health concepts including general health, physical functioning, role functioning, bodily pain, mental health, emotional functioning, vitality, and social functioning.
|
Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline and 12th session at the end of 4th week.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hand Held Dynamometer to check gluteus medius muscle strength
Time Frame: Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
The strength of the gluteus medius muscle was assessed on the dominant side using the Microfet2 hand-held dynamometer (MicroFET 2, Hoogan Health Industries, West Jordan, UT, USA).
|
Total duration of treatment is 4 weeks and 12 sessions, 3 sessions per week on alternate days. Patients will be assessed at baseline, at 6th session at the end of 2nd week and 12th session at the end of 4th week.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rabail Soomro, University of Lahore
- Study Chair: Hussain Kari mi, University of Lahore
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sacroiliac Disorder
-
SI-BONE, Inc.RecruitingSacroiliac Joint Pain | Sacroiliac Joint Dysfunction | Sacroiliac Disorder | Sacroiliac; FusionUnited States
-
Cairo UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Universidad Católica San Antonio de MurciaUnknownSacroiliac DisorderSpain
-
Poznan University of Physical EducationCompletedAsymptomatic Condition | Sacroiliac DisorderPoland
-
Riphah International UniversityCompletedSacroiliac DisorderPakistan
-
Logan College of ChiropracticUnknownSacroiliac FunctionUnited States
-
University of ExtremaduraCompletedLow Back Pain | Sacroiliac DisorderSpain
-
University of BergenOslo University HospitalCompletedSacroiliac InstabilityNorway
-
University of BergenOslo University HospitalNot yet recruiting
Clinical Trials on physiotherapy
-
Hacettepe UniversityCompleted
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
University of OviedoCompletedParkinson Disease
-
Isra UniversityCompleted
-
University of Nove de JulhoUniversidade Federal do CearáRecruitingEdema | ParesthesiaBrazil
-
Ambreen ChohanBlackpool Victoria HospitalCompletedKnee Osteoarthritis | Exercise | Rehabilitation | Physiotherapy | InterventionUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated
-
Centre Hospitalier Universitaire de Saint EtienneCompleted